FDA applicant
Medtronic Vascular
FDA records 500 decisions for Medtronic Vascular (Minneapolis, MN) from 1977 to 2023: 480 510(k) clearances and 20 original PMA approvals. Most are in product codes DTB (Permanent Pacemaker Electrode) and DXY (Implantable Pacemaker Pulse-Generator). Since 2016 its 510(k)s took a median of 111 days from receipt to decision, against 95 for FDA’s reviews in the same codes and years. Its devices cite 235 predicates, 82 of them its own earlier devices. 366 recalls are linked to its devices, 195 Class I.
FDA’s records also spell it “Medtronic Vascular, Inc.”.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Medtronic Vascular’s devices, and how often a recall has named them.
FDA decisions per year
3in 2023
2026 so far, outlined.
Recalls per year
1in 2026
Class I Class II/III not classified
Planning a device like Medtronic Vascular’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report